Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON)

Lung Cancer

Volumn 69, Issue 1, 2010, Pages 66-70

  Baecke, Eleonora ^a   de Koning, Harry J ^a   Otto, Suzie J ^a   van Iersel, Carola A ^a,b   van Klaveren, Rob J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

Contamination; Early detection of cancer; Lung cancer; Lung neoplasms; Mass screening; NELSON trial; Power; Randomized controlled trial; Screening; Tomography spiral computed

Indexed keywords

ACCURACY; AGE; ARTICLE; BELGIUM; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; HIGH RISK PATIENT; HUMAN; LUNG CANCER; NETHERLANDS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; SYSTEMATIC ERROR; THORAX RADIOGRAPHY; AGED; CONTROL GROUP; EARLY DIAGNOSIS; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING;

AGED; BELGIUM; CONTROL GROUPS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953359064     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.08.015     Document Type: Article

References (11)

1. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., Coebergh J.W.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44:1345-1389.
2. Comprehensive Cancer Centres, the Netherlands. Retrieved from: , cijfers (18 February 2009). http://www.ikcnet.nl/.
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
4. Janssen-Heijnen M.L., Coebergh J.W. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001, 31:123-137.
5. Mulshine J.L., Sullivan D.C. Clinical practice. Lung cancer screening. N Engl J Med 2005, 352:2714-2720.
6. van Iersel C.A., de Koning H.J., Draisma G., Mali W.P., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120(4):868-874.
7. Otto S.J., van der Cruijsen I.W., Liem M.K., Korfage I.J., Lous J.J., Schroder F.H., et al. Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. Int J Cancer 2003, 105:394-399.
8. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph, The Lung Screening Study of the National Cancer Institute. Chest 2004, 126:114-121. The Lung Screening Study Research Group.
9. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009, 180(5):445-453. DANTE Study Group.
10. Mortality results from a randomized prostate cancer screening trial. N Engl J Med 2009, PLCO Project Team, published March 18 2009 at www.nejm.org.
11. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009, ERSPC Investigators, published March 18 2009 at www.nejm.org.